SIROLIMUS vs VONJO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. SIROLIMUS and VONJO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SIROLIMUS	VONJO
Rating	66/100	New
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	PACRITINIB CITRATE
Manufacturer	Apotex	Sobi
Dosage forms	Solution	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Primary Myelofibrosis

sirolimus vonjo

Rating

66/100

New

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

PACRITINIB CITRATE

Manufacturer

Apotex

Sobi

Dosage forms

Solution

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Primary Myelofibrosis

Frequently asked questions

What is the difference between Sirolimus and Vonjo?

Sirolimus contains Sirolimus, while Vonjo contains Pacritinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.